Primary treatment in stage II non-seminomatous germ cell tumours of the testis: A matter of scalpel or drug infusion?

European Journal of Cancer Part A

Volumn 32, Issue 10, 1996, Pages 1641-1644

  Culine, S ^a   Droz, J P ^b  

^a CENTRE VAL D AURELLE   (France)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

Chemotherapy; Retroperitoneal lymph node dissection; Retropiritoneal metastases; Stage II; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE DISSECTION; MALE; METASTASIS; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; REVIEW; TESTIS TUMOR;

EID: 0030249879     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00163-3     Document Type: Note

References (31)

1. 1. Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990, 8, 1777-1781.
2. 2. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Clinical stage B nonseminomatous germ cell testis cancer: the Indiana University experience (1965-1989) using routine primary retroperitoneal lymph node dissection. Eur J Cancer 1995, 31A, 1599-1604.
3. 3. Donohue JP, Thornhill JA, Foster RS, Bihrle R, Rowland RG, Einhorn LH. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989). J Urol 1995, 153, 85-89.
4. 4. Pizzocaro G, Monfardini S. No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol 1984, 131, 677-680.
5. 5. Logothetis CJ, Swanson DA, Dexeus F, et al. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients. J Clin Oncol 1987, 5, 906-911.
6. 6. Horwich A, Norman A, Fisher C, Hendry WF, Nicholls J, Dearnaley DP. Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis. J Urol 1994, 15, 72-78.
7. 7. McLeod DG, Weiss RB, Stablein DM, et al. Staging relationships and outcome in early stage testicular cancer: a report from the testicular cancer intergroup study. J Urol 1991, 145, 1178-1183.
8. 8. Pizzocaro G, Piva L, Salvioni R, et al. Adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis. In which cases is it necessary? Eur Urol 1984, 10, 151-158.
9. 9. Richie JP, Kantoff PW. Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol 1991, 9, 1393-1396.
10. 10. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Birhle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-1989): modifications of technique and impact on ejaculation. J Urol 1993, 149, 237-243.
11. 11. Donohue JP, Foster RS, Rowland RG, Birhle R, Jones J, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990, 144, 287-292.
12. 12. Javadpour N. Predictors of recurrence in stage II nonseminomatous testicular cancer after lymphadenectomy: implications for adjuvant chemotherapy. J Urol 1984, 135, 629.
13. 13. Vogelzang NJ, Fraley EE, Lange PH, Torkelson J, Levitt S, Kennedy BJ. Stage II nonseminomatous testicular cancer: a 10-year experience. J Clin Oncol 1983, 1, 171-178.
14. 14. Williams SD, Stablein DM, Einhorn LH, et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular at relapse in pathological stage II testicular cancer. N Engl J Med 1987, 317, 1433-1438.
15. 15. Weissbach L, Hartlapp JH. Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor. J Urol 1991, 146, 1295-1298.
16. 16. Motzer RJ, Sheinfeld J, Mazumdar M, et al. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors. J Clin Oncol 1995, 13, 2700-2704.
17. 17. Culine S, Théodore C, Farhat F, Bekradda M, Terrier-Lacombe MJ, Droz JP. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell rumors. J Surg Oncol 1996, 61, 195-198.
18. 18. Culine S, Théodore C, Terrier-Lacombe MJ, Droz JP. Chemotherapy in stage II nonseminomatous germ cell tumors of the testis: the Institut Gustave Roussy experience. Urol Oncol 1996, 1, 175-183.
19. 19. Bosl GJ, Geller NL, Bajorin D, et al. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. J Clin Oncol 1988, 6, 1231-1238.
20. 20. Einhorn LH, Williams SD, Loehrer PJ, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol 1989, 7, 387-391.
21. 21. Loehrer PJ, Johnson DH, Elson P, Einhorn LH, Trump D. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J Clin Oncol 1995, 13, 470-176.
22. 22. Bokemeyer C, Schmoll HJ. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol 1995, 13, 283-292.
23. 23. Boshoff C, Begent RHJ, Oliver RTD. Secondary tumours following etoposide containing therapy for germ cell cancer. Ann Oncol 1995, 6, 35-40.
24. 24. Stephenson WT, Poirier SM, Rubin L, Einhorn LH. Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin. J Clin Oncol 1995, 13, 2278-2280.
25. 25. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 1995, 153, 976-980.
26. 26. Steyerberg EW, Keiser HJ, Fossa SD, et al. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 1995, 13, 1177-1187.
27. 27. Toner GC, Panicek DM, Heelan RT, et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 1990, 8, 1683-1694.
28. 28. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982, 128, 315-320.
29. 29. Wood DP, Herr HW, Heller G, et al. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol 1992, 148, 1812-1816.
30. 30. Aprikian AG, Herr HW, Bajorin D, Bosl GJ. Resection of post-chemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 1994, 74, 1329-1334.
31. 31. Baniel J, Roth BJ, Foster RS, Donohue JP. Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors. Cancer 1995, 75, 2897-2903.